medigraphic.com

2010, Number 4

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2010; 48 (4)

Pleural mesothelioma in paraoccupational, environmental and occupational patients exposed to asbestos

Méndez-Vargas MM, López-Rojas P, Campos-Pujal GA, Marín-Cotoñieto IA, Salinas-Tovar S, Fernández-Muñoz MJ

Language: English
References: 27
Page: 361-366
PDF size: 36.13 Kb.


ABSTRACT

Objective: to identify the characteristics of pleural mesothelioma in patients exposed to asbestos.
Methods: a transversal study in 3700 cases of lung cancer was conducted. There were identified 21 cases with mesothelioma. Age, gender, smoking history, cancer development, dissemination, cytohistochemistry, lethality and total lung capacity were studied. ANOVA test was used.
Results: the incidence was of 0.45/100,000 patients. Four (19 %) corresponded to occupational exposure (OE), seven (33 %) para-occupational (PE) and ten (48 %) environmental (EE). The mean age at detection was 50 years for PE, 55 years for EE and 64 years for OE. Twenty cases were male. Thirteen patients (62 %) were active cigarette smokers. The latency time in PE mesothelioma was 34.5 years, in OE 40 years, and in EE more than 40 years. In 19 (90 %) cases the tumor was disseminated. Diagnosis was confirmed by cytohistochemistry. Malignant mesothelioma was reported in 19 (90 %) cases. The survival period was 5 months for OE patients, 10 in PE and 16 in EE.
Conclusions: there is a low incidence of malignant mesothelioma in our population. Male was the predominant group. Occupational and paraoccupational exposure predominated in patients.


REFERENCES

  1. Energy, Mines and Resources Canada. El amianto. Ottawa, Canada. Energy, Mines and Resources Canada; 1986.

  2. Parkes WR. Occupational lung disorders. London: Butterworth; 1982. p. 134-174.

  3. Méndez M, Maldonado T. Enfermedades producidas por el asbesto. México: Instituto Mexicano del Seguro Social, Subdirección General Médica; 1984.

  4. Parkes W. Asbestos-related disorders. Br J Dis Chest 1973;67(4):261-300.

  5. Parkes WR. Occupational lung disorders. Third edition. London: Butterworth; 1994.

  6. Cano V, Núñez P, Cardoso R, Lugo P, Colinabarranco En: Barrios VG, Criales C. Pleura. México: Universidad Nacional Autónoma de México/Piensa; 1991.

  7. Instituto Mexicano del Seguro Social. Memoria estadística de salud en el trabajo. México: IMSS; 2003.

  8. Maldonado T, Méndez M. Enfermedades broncopulmonares de trabajo. En: Maldonado T, editor. Enfermedades por contaminación del ambiente de trabajo. México: Auroch; 1999.

  9. Wagner JC. The sequels of exposure to asbestos dust. Ann N Y Acad Sci 1965;132(1):691-695.

  10. Selikoff IJ, Hammond EC, Chung J. Carcinogenicity of amosite asbestos. Arch Environ Health 1972; 25(3):183-186.

  11. Pan XL, Day HW, Wang W, Beckett LA, Schenler MB. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172(8):1019-1025.

  12. Morgan WK, Gee JBL. Asbestos-related diseases. En: Morgan WK, Seaton A, editors. Occupational lung diseases. Philadelphia: WB Saunders; 1995. p. 350-361.

  13. Parkes WR. Asbestos-related disorders. Br J Dis Chest 1973;67(4):261-300.

  14. Becklake MR. Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am Rev Resp Dis 1976;114(1):187-227.

  15. Wyers H. That legislative measures have provedgenerally effective in the control of asbestosis. [Thesis Doctor of Medicine]. Scotland, UK: University of Glasgow; 1946.

  16. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in North Eastern Cape Province. Br J Ind Med 1960; 17:260-271.

  17. Wagner JC, Gilson JC, Berry G, Timbrell V. Epidemiology of asbestos cancers. Br Med Bull 1971; 27:71-76.

  18. Newhouse ML, Berry G, Wagner JC. Turok ME. A study of the mortality of female asbestos workers. Br J Ind Med 1972;29(2):134-141.

  19. Greenberg S, Hurst GA, Christianson SC, Matlage WJ. Pulmonary cytopathology of former asbestos workers. Report of the first year. Am J Clin Pathol 1976;66(5):815-822.

  20. Méndez VM, Maldonado TM, Stanislawski EC, Mendoza HA. Mesotelioma maligno en un trabajador del asbesto. Rev Med IMSS 1982;20(3): 249-557.

  21. Méndez V, Maldonado T. Tumores malignos relacionados con la exposición industrial al asbesto en México. Rev Med IMSS 1992;30(1):43-46.

  22. Berry M. Mesothelioma incidence and community asbestos exposure. Environ Res 1997;75(1): 34-40.

  23. Kjaergaars J, Michelsen E. Malignant mesothelioma incidence survival and relative risk in selected municipalities 1943-1992. Uerkrift Laeger 1997;159(31):4756-4761.

  24. Boutin C, Schlesser M, Frenay C, Astoul P. Malignant pleural mesothelioma. Eur Resp J 1998;12 (4):972-981.

  25. Yeung P, Rogers A. An occupational industry matrix analysis of mesothelioma cases in Australia 1980-1985. Appl Occup Environ Hyg 2001;16(1): 40-44.

  26. Magnany C, Agudo A, González C, Andrion A, Calleja A, Chellini E, et al. Multicentric study on malignant pleural mesothelioma and nonoccupational exposure to asbestos. Br J Cancer 2000; 83(1)104- 111.

  27. Koskinen K, Pukkala E, Martikainen R, Reijula K, Karjalainen A. Different measures of asbestos exposure in estimating risk of lung cancer and mesothelioma among construction workers. J Occup Environ Med 2002;44(12):1190-1196.




2020     |     www.medigraphic.com